NEW YORK (GenomeWeb) – NantHealth reported after the close of the market on Monday that its third quarter revenues rose 76 percent year over year, thanks largely to a 252 percent increase in sales from its software platforms such as NantOS.

For the quarter ended Sept. 30, the company reported revenues of $25.4 million, up from $14.4 million a year earlier. However, it missed Wall Street analysts' average estimate for revenues of $26.4 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.